Travis Ayers Institution-verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Researcher
faculty
Research Areas
Biography and Research Information
OverviewAI-generated summary
Travis Ayers' research focuses on pediatric gastrointestinal and immune system disorders, with a particular emphasis on inflammatory bowel diseases like ulcerative colitis and Crohn's disease. His work includes investigating treatment responses in young patients, as evidenced by his publications on the use of Tofacitinib in pediatric ulcerative colitis and the ACR Appropriateness Criteria for Crohn Disease in children. Ayers has also explored the impact of atopic status on clinical presentation and treatment outcomes in pediatric eosinophilic esophagitis. His scholarship metrics include an h-index of 5, with 7 total publications and 97 citations. Key collaborators at the University of Arkansas for Medical Sciences include Stacie M. Jones, Christina Tootle, and Chary Akmyradov, with whom he has co-authored publications.
Metrics
- h-index: 5
- Publications: 7
- Citations: 100
Selected Publications
-
Dupilumab Failures in Pediatric and Adolescent Eosinophilic Esophagitis: A Retrospective Cohort Study (2026)
-
Impact of Atopic Status on Clinical Presentation and Treatment Response in Pediatric Patients With Eosinophilic Esophagitis (2024)
-
Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience (2024)
Collaboration Network
Top Collaborators
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
- P628 Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
- Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease: A Series of N-of-1 Diet Trials
- Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease: A Series of N-of-1 Diet Trials
- Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease: A Series of N-of-1 Diet Trials
Similar Researchers
Based on overlapping research topics